Smoking and smoking cessation-The relationship between cardiovascular disease and lipoprotein metabolism: A review

Atherosclerosis

Volumn 201, Issue 2, 2008, Pages 225-235

  Campbell, Sara Chelland ^a   Moffatt, Robert J ^a   Stamford, Bryant A ^b  

^a FLORIDA STATE UNIVERSITY   (United States)

^b HANOVER COLLEGE   (United States)

Author keywords

Carbon monoxide; Cardiovascular disease; Cigarette smoking; Lipid transport enzymes; Lipids; Lipoproteins; Metabolism; Nicotine

Indexed keywords

CARBON MONOXIDE; CATECHOLAMINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NICOTINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATECHOLAMINE BLOOD LEVEL; CAUSE OF DEATH; HEART INFARCTION; HEART RATE; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; REVIEW; SMOKING; SMOKING CESSATION; UNITED STATES;

CARBON MONOXIDE; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; NICOTINE; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 56649083647     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.04.046     Document Type: Review

References (110)

1. Rosamond W., et al. Heart Disease and Stroke Statistics-2007, update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
2. US Department of Health and Human Services. Reducing tobacco use: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2000.
3. Troiano R.P., and Flegal K.M. Overweight prevalence among youth in the US. Why so many different numbers?. Int J Obes Rel Met Dis 23 (1999) S22-S27
4. Johnson P.B., and Richter L. The relationship between smoking, drinking, and adolescents self-perceived health and frequency of hospitalization: analysis from the 1997 National Household Survey on Drug Abuse. J Adolesc Health 30 3 (2002) 175-183
5. National Cholesterol Education Program. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). NIH Publication No. 01-3670. Department of Health and Human Services, National Institutes of Health, NHLBI; 2001.
6. Kannel W.B., Dawber T.R., Friedman G.D., Glennan W.E., and McNamara P.M. Risk factors in coronary heart disease. An evaluation of several serum lipids as predictors of coronary heart disease. The Framingham Study. Ann Intern Med 61 (1964) 888-899
7. Roma M. Factors related to sudden death in acute ischaemic heart disease. A community study in Helsinki. Acta Med Scand Suppl 547 (1972) 1-92
8. Holme I. Coronary risk factors and their possible causal role in the development of coronary heart disease: the Oslo study. J Oslo City Hosp 32 (1982) 80
9. Srinivasan S.R., Webber L.S., and Berenson G.S. Lipid composition and interrelationships of major serum lipoproteins. Observations in children with different lipoprotein profiles. Bogalusa Heart Study. Arteriosclerosis 2 (1982) 335
10. MRFIT Research Group. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Prev Med 15 3 (1986) 254
11. Dawber T.R., Moore Jr. F.E., and Mann G.V. Coronary heart disease in the Framingham Study. Am J Pub Health 47 (1957) 4
12. Criqui M.H., Wallace R.B., Heiss G., Mishkel M., Schonfeld G., and Jones G.T.L. Cigarette smoking and plasma high density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation 62 (1980) IV70-76
13. Kannel W.B. Cardiovascular risk assessment. In: Moffatt R.J., and Stamford B. (Eds). Lipid metabolism and health (2006), CRC Press/Taylor & Francis, Boca Raton, FL 13-31
14. Gordon T., and Kannel W.B. Premature mortality from coronary heart disease. JAMA 215 10 (1971) 1617-1625
15. Kagan A., Rhoads G.G., Zeegan P.D., and Nichaman M.Z. Coronary heart disease among men of Japanese ancestry in Hawaii. The Honolulu Heart study. Isr J Med Sci 7 12 (1971) 1573-1577
16. Miller N.E. The Tromoso heart study. High density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1 (1977) 965
17. Kostner G.M. Apolipoproteins and lipoproteins of human plasma: significance in health and disease. Adv Lipid Res 20 (1983) 1-43
18. National Health Interview Survey, selected years-United States. Number (in millions) of adults 18 years and older who were current, former, or never smokers, overall and by sex, race, Hispanic origin, age, and education. Centers for Disease Control, National Center For Chronic Disease Prevention and Health Promotion (TIPS); 1965-2000.
19. National Health Interview Survey (NHIS). Centers for Disease Control and Prevention, National Center for Health Statistics; 2003.
20. Huchard H. Maladies du Coeur et des vaisseaux. Treaty of Cardiology. Paris Doin; 1889.
21. Lewis T. Diseases of the heart (1933), The Macmillan Company, UK
22. Levine S.A. Clinical heart disease (1950), Williams and Wilkens, Baltimore, MD
23. Hammond E.C., and Horn D. Smoking and death rates: report on forty-four months of follow-up of 187,783 men. II. Death rates by cause. JAMA 166 (1958) 1294-1308
24. Doll R., and Hill J.B. The mortality of doctors in relation to their smoking habits. Br Med J 1 (1954) 1451-1455
25. Doll R., Peto R., Boreham J., and Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. Br Med J 328 (2004) 1519-1528
26. Craig W.Y., Palomaki G.E., and Haddow J.E. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 298 (1989) 784-788
27. Law M.R., Morris J.K., and Wald N.J. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. Br Med J 315 (1997) 980
28. McGill Jr. H.C. The cardiovascular pathology of smoking. Am Heart J 115 (1988) 250-257
29. Moriguchi E.H., Fusegawa Y., Tamacchi H., and Goto Y. Effects of smoking on HDL subfractions in myocardial infarction patients: effects on leithin cholesterol acyl transferase and hepatic lipase. Clin Chim Acta 195 (1990) 139-144
30. Freeman D.J., Griffin B.A., Murray E., et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest 23 (1993) 630-640
31. McCall M.R., van den Berg J.J.M., Kuypers F.A., et al. Modification of LCAT activity and HDL structure: new links between cigarette smoke and coronary heart disease. Arteriosc Thromb 14 (1994) 248-253
32. Facchini F.S., Hollenback C.B., Jeppesen J., Chen Y.-D., and Reaven G.M. Insulin resistance and cigarette smoking. Lancet 339 (1992) 1128-1130
33. Eliasson B., Attvall S., Taskinen M.-R., and Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arteriosc Thromb 14 (1994) 1946-1950
34. Kong C., Nimano L., Elatroy T., et al. Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidemia and early atherosclerosis in type 2 diabetes. Atherosclerosis 156 2 (2001) 373-378
35. Benowitz N.L. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 319 (1988) 1318-1330
36. Chajek-Shaul T., Berry E.M., Ziv E., et al. Smoking depresses adipose lipoprotein lipase response to oral glucose. Eur J Clin Invest 20 (1990) 299-304
37. Hellerstein M.K., Benowitz N.L., Neese R.A., et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest 93 (1994) 265-272
38. Freeman D.J., Caslake M.J., Griffin B.A., et al. The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesterol ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma. Eur J Clin Invest 28 (1998) 584-591
39. Elkels R.S., Khan S.R., Chowdhury V., and Swallow M.B. Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol. Clin Sci 65 (1983) 669-672
40. Pittilo R.M., and Woolf N. Cigarette smoking as a risk factor for atherosclerosis. J Smoking-Related Dis 5 (1994) 43-47
41. Campos H., Genest J.J., Blijevens E., et al. Low density lipoprotein particle size and coronary heart disease. Arteriosc Thromb 12 (1992) 187-195
42. Griffin B.A., Freeman D.J., Tait G.W., et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small dense LDL to coronary heart disease risk. Atherosclerosis 106 (1994) 241-253
43. Killburn K.H. Stop inhaling smoke: prevent coronary heart disease. Arch Environ Health 58 2 (2003) 68-73
44. van Tits L.J., de Waart F., Hak-Lemmers H.L., et al. Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers. Free Rad Biol Med 30 10 (2001) 1122-1129
45. Ohashi R., Mu H., Wang X., Yao Q., and Chen C. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. Q J Med 98 (2005) 845-856
46. Shennan N.M., Seed N.M., and Wynn V. Variation in serum lipid and lipoprotein levels associated with changes in smoking behavior in non-obese Caucasian males. Atherosclerosis 58 (1985) 17-25
47. Haffner S.M., Applebaum-Bowden D., Wahl P.W., et al. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D and lecithin cholesterol acyltransferase. Effects of smoking, alcohol and adiposity. Atherosclerosis 5 2 (1985) 169-177
48. Moffatt R.J., Biggerstaff K.D., and Stamford B.A. Effects of the transdermal nicotine patch on normalization of HDL-C and its subfractions. Prev Med 31 (2000) 148-152
49. Berg K., Borresen A.-L., and Dahlen G. Effect of smoking on serum levels of HDL apoproteins. Atherosclerosis 34 (1979) 339-343
50. Zaratin ACM, Quintao EDR, Sposito AC, et al. Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport; 2004.
51. Dullart R.P.F., Hoogenberg K., Dikkeschu B.D., and van Tol A. High plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette smoking men. Aterioscler Thromb 14 (1995) 1581-1585
52. Carlson L.A., and Holmquist L. Evidence for deficiency of high density lipoprotein lecithin:cholesterol acyltransferase activity (alpha-LCAT) in fish eye disease. Acta Med Scand 218 (1985) 189-196
53. Wilson P.W.F., Garrison R.J., Abbott R.D., and Castelli W.P. Factors associated with lipoprotein cholesterol levels: the Framingham Study. Arteriosclerosis 3 (1983) 273-281
54. Stamford B.A., Matter S., Fell R., Sady S., Cresanta M.K., and Papanek P. Cigarette smoking, physical activity, and alcohol consumption: relationship to blood lipids and lipoproteins in premenopausal females. Metabolism 33 (1984) 585-590
55. Tuomilehto J., Tanskanen A., Salonen J.T., Nissenen A., and Koskela K. Effects of smoking and stopping smoking on serum high density lipoprotein cholesterol levels in a representative population sample. Prev Med 15 (1986) 35-45
56. Muscat J.E., Harris R.E., Haley N.J., and Wynder E.L. Cigarette smoking and plasma cholesterol. Am Heart J 121 (1991) 141-147
57. Green M.S., and Harari G. A prospective study on the effects of changes in smoking habits of blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men, the Israeli Cordis Study. J Clin Epidemiol 48 9 (1995) 1159-1166
58. Li Z., Barrios V., Buchholz J.N., Glenn T.C., and Duckles S.P. Chronic nicotine administration does not affect peripheral vascular reactivity in the rat. J Pharmacol Exp Ther 271 (1994) 1135-1142
59. Mayhan W.G., and Sharpe G.M. Chronic exposure to nicotine alters endothelium dependent arteriolar dilatation: effect of superoxide dismutase. J Appl Physiol 86 (1999) 1126-1134
60. Clouse W.D., Yamaguchi H., Phillips M.R., et al. Effects of transdermal nicotine treatment on structure and function of coronary artery bypass grafts. J Appl Physiol 89 (2000) 1213-1223
61. Sun Y.P., Zhu B.Q., Browne A.E., et al. Nicotine does not influence arterial lipid deposits in rabbits exposed to second hand smoke. Circulation 104 (2001) 810-814
62. Smith C.J., and Fischer T.H. Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis 158 (2001) 257-267
63. Moskowitz W.B., Mosteller M., Hewitt J.K., Eaves L.J., Nance W.E., and Shieken R.M. Univariate genetic analysis of oxygen transport regulation in children: the Medical College of Virginia Study. Pediatr Res 33 (1993) 645-648
64. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43 10 (2004) 1731-1737
65. Astrup P., and Kjeldsen K. Model studies linking carbon monoxide and/or nicotine to arteriosclerosis and cardiovascular disease. Prev Med 8 (1979) 295-302
66. Penn A., Currie J., and Synder C. Inhalation of carbon monoxide does not accelerate arteriosclerosis in cockerels. Eur J Pharmacol 228 (1992) 155-164
67. Zevin S., Saunders S., Gourlay S.G., Jacob P., and Benowitz N.L. Cardiovascular effects of carbon monoxide and cigarette smoking. J Am Coll Cardiol 38 (2001) 1633-1638
68. Mustard J.F., and Packham. The role of blood and platelets in atherosclerosis and the complications of atherosclerosis. Thromb Diath Haemorr 33 (1975) 444-456
69. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 314 (1986) 488-500
70. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
71. Waters D., Lesperance J., Gladstone P., et al. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis: a Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy. Circulation 94 (1996) 614-621
72. Slow R.C.M., Sato H., and Mann G.E. Heme oxygenase carbon monoxide signaling pathway in atherosclerosis: antiatherogenic actions of bilirubin and carbon monoxide. Cardiol Res 41 (1999) 385-394
73. Schmidt K.G., and Rasmussen J.W. Acute platelet activation induced by smoking. In vivo and ex vivo studies in humans. Thromb Haemo 51 (1984) 279-282
74. Blache D., Bouthillier D., and Davignon J. Acute influence of smoking on platelet behviour, endothelium and plasma lipids and normalization by aspirin. Atherosclerosis 93 (1992) 179-188
75. Kharitonov S.A., Robbins R.A., Yates D., Keating V., and Barnes P.J. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 152 (1995) 609-612
76. Wang X.L., Sim A.S., Wang M.X., Murrell G.A.C., Trudinger B., and Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 471 (2000) 45-50
77. Diez-Roux A.V., Nieto F.J., Comstock G.W., Howard G., and Szklo M. The relationship of active and passive smoking to carotid atherosclerosis 12-14 years later. Prev Med 24 (1995) 48-55
78. Howard G., Burke G.L., Szklo M., et al. Active and passive smoking are associated with increased carotid wall thickness: the atherosclerosis risk in communities study. Arch Int Med 154 (1994) 1277-1282
79. Tell G.S., Polak J.F., Ward B.J., Kittner S.J., Savage P.J., and Robbins J. Relations of smoking with carotid artery wall thickness and stenosis in older adults: the cardiovascular health study. Circulation 90 (1994) 2905-2908
80. Vidrine J.I., Anderson C.B., Pollack K.I., and Wetter D.W. Gender differences in adolescent smoking: mediator and moderator effects of self-generated expected smoking outcomes. Am J Health Promt 20 (2006) 383-387
81. Schmitz J.M. Smoking cessation in women with cardiac risk. Am J Med Sci 326 (2003) 192-196
82. Carpenter M.J., Upadhyaya H.P., Larowe S.D., Saladin M.E., and Brady K.T. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tobacco Res 8 (2006) 627-638
83. Cullen P., Schulte H., and Assmann G. Smoking, lipoproteins and coronary heart disease risk. Data from the Munster Heart Study (PROCAM). Eur Heart J 19 (1998) 1632-1641
84. Kuulasmaa K., Tunstall-Pedoe H., Dobson A., et al. Estimation of contribution of changes in classic risk factors to trends in coronary event rates across WHO MONICA project populations. Lancet 355 (2000) 675-687
85. Feeman W.E. The role of cigarette smoking in athersclerotic disease: an epidemiologic analysis. J Cardiol Res 6 (1999) 333-336
86. Bolego C., Poli A., and Paoletti R. Smoking and gender. Cardiol Res 53 (2002) 568-576
87. Wolf P.A., D'Agostino R.B., Kannel W.B., Bonita R., and Belanger A.J. Cigarette smoking as a risk factor for stroke: the Framingham Heart Study. JAMA 259 (1988) 1025-1029
88. Rosenburg L., Palmer J.R., and Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 322 (1990) 213-217
89. La Croix A.Z., Lang J., Scherr P., et al. Smoking mortality among older men and women in three communities. N Engl J Med 324 (1991) 1619-1625
90. Tverdal A., Thelle D., Stensvold I., Leren P., and Bjartveit K. Mortality in relation to smoking history: 13 years follow-up of 68,000 Norwegian men and women 35-49 years old. J Clin Epidemiol 46 (1993) 475-487
91. Maeda K., Noguchi Y., and Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med 37 (2003) 283-290
92. Moffatt R.J., Stamford B.A., Owens S.G., and Chitwood L.F. Cessation from cigarette smoking: lipoprotein changes in men and women. J Smoking-Related Dis 3 1 (1992) 11-19
93. Stubbe I., Eskilsson J., and Nilsson-Ehle P. High density lipoprotein concentrations increase after stopping smoking. Br Med J 284 (1982) 1511-1513
94. Stamford B.A., Matter S., Fell R., and Papanek P. Effects of smoking cessation on weight gain, metabolic rate, caloric consumption and blood lipids. Am J Clin Nutr 43 (1986) 486-494
95. Moffatt R.J. Effects of cessation of smoking on serum lipids and high density lipoprotein cholesterol. Atherosclerosis 74 (1988) 85-89
96. Moffatt R.J. Normalization of high density lipoprotein cholesterol following cessation from cigarette smoking. In: Diana J.N. (Ed). Tobacco smoking and atherosclerosis: pathogenesis and cellular mechanisms (1990), Plenum Press, New York 267-272
97. Quensel M., Soderstrom A., Agardh C.D., and Nilsson-Ehle P. High density lipoprotein concentrations after cessation of smoking: the importance of alterations in diet. Atherosclerosis 75 (1989) 189-193
98. Allen S.S., Hatsukami D., and Gorsline J. Cholesterol changes in smoking cessation using the transdermal nicotine system. Transdermal Nicotine Study Group. Prev Med 23 (1994) 190-196
99. Thomas G.A.O., Davies S.V., Rhodes J., Russell M.A.H., Feyerabend C., and Sawe U. Is transdermal nicotine associated with cardiovascular risk?. J R Col Phys Lond 29 (1995) 392-1392
100. Assaf A.R., Parker D., Lapane K.L., Coccio E., Evangelou E., and Carleton R.A. Does the Y chromosome make a difference? Gender differences in attempts to change cardiovascular disease risk factors. J Womens Health 12 (2003) 321-330
101. Cepeda-Benito A., Reynoso J.T., and Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J Consult Clin Psychol 72 (2005) 712-722
102. Hatsukami D.K., Hughes J.R., Pickens R.W., and Svikis D.S. Tobacco withdrawl symptoms: an experimental analysis. Psychopharmology 84 2 (1984) 231-236
103. Hughes J.R., and Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiat 43 3 (1986) 289-294
104. Gerace T.A., Hollis J., Ockene J.K., and Svendsen K. Smoking cessation and change in diastolic blood pressure, body weight, and plasma lipids. MRFIT Research Group. Prev Med 20 (1991) 602-620
105. Moffatt R.J., and Owens S. Cessation from cigarette smoking: changes in body weight, body composition, resting metabolism and energy consumption. Metab Clin Exp 40 (1991) 465-470
106. Oeser A., Goffaux J., Snead W., and Carlson M.G. Plasma leptin concentrations and lipid profiles during nicotine abstinence. Am J Med Sci 318 (1999) 152-157
107. Niaura R., Marcus B., Albrecht A., Thompson P., and Abrams D. Exercise, smoking cessation, and short-term changes in serum lipids in women: a preliminary investigation. Med Sci Sport Exer 30 9 (1998) 1414-1418
108. Njolstad I., Arnesen E., and Lund-Larsen P.G. Smoking, serum lipids, blood pressure and sex differences in myocardial infarction. Circulation 93 (1996) 450-456
109. Eliasson B., Mero N., Taskinen M.R., and Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 129 1 (1997) 79-88
110. Kilburn K.H. Stop inhaling smoke: prevent coronary heart disease. Arch Environ Health 58 2 (2003) 68-73